jain.com

Warrant issuance (first tranche)

Company: Applied Digital

This claim was marked delayed on September 4, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2024-06-06
Promised by
2024-06-17
Promised amount
6300449.0 shares
Current status
delayed

The claim, verbatim

Company will issue warrants to purchase 6,300,449 common shares with exercise price of $4.8005 per share, to be issued no later than June 17, 2024 in a registered direct issuance

Source (primary)

Applied Digital 8-K filed 2024-06-07 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “The Warrants will be issuable in two tranches for the purchase of up to 6,300,449 Common Shares and 2,964,917 Common Shares, respectively. The first tranche will be issued no later than June 17, 2024 in a registered direct issuance.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms Applied Digital 8-K filed 2024-06-07

Quote: “The Warrants will be issuable in two tranches for the purchase of up to 6,300,449 Common Shares and 2,964,917 Common Shares, respectively. The first tranche will be issued no later than June 17, 2024 in a registered direct issuance.”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 3, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 4, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.